BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24186380)

  • 1. CYP1A1 and CYP1B1-mediated biotransformation of the antitrypanosomal methamidoxime prodrug DB844 forms novel metabolites through intramolecular rearrangement.
    Ju W; Yang S; Ansede JH; Stephens CE; Bridges AS; Voyksner RD; Ismail MA; Boykin DW; Tidwell RR; Hall JE; Wang MZ
    J Pharm Sci; 2014 Jan; 103(1):337-49. PubMed ID: 24186380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro metabolism of an orally active O-methyl amidoxime prodrug for the treatment of CNS trypanosomiasis.
    Ansede JH; Voyksner RD; Ismail MA; Boykin DW; Tidwell RR; Hall JE
    Xenobiotica; 2005 Mar; 35(3):211-26. PubMed ID: 16019947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of DB844, an orally active aza analogue of pafuramidine, in a monkey model of second stage human African trypanosomiasis.
    Thuita JK; Wang MZ; Kagira JM; Denton CL; Paine MF; Mdachi RE; Murilla GA; Ching S; Boykin DW; Tidwell RR; Hall JE; Brun R
    PLoS Negl Trop Dis; 2012; 6(7):e1734. PubMed ID: 22848769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and metabolism of the prodrug DB289 (2,5-bis[4-(N-methoxyamidino)phenyl]furan monomaleate) in rat and monkey and its conversion to the antiprotozoal/antifungal drug DB75 (2,5-bis(4-guanylphenyl)furan dihydrochloride).
    Midgley I; Fitzpatrick K; Taylor LM; Houchen TL; Henderson SJ; Wright SJ; Cybulski ZR; John BA; McBurney A; Boykin DW; Trendler KL
    Drug Metab Dispos; 2007 Jun; 35(6):955-67. PubMed ID: 17360833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
    Chang TK; Chen J; Yang G; Yeung EY
    J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP4F enzymes are the major enzymes in human liver microsomes that catalyze the O-demethylation of the antiparasitic prodrug DB289 [2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime].
    Wang MZ; Saulter JY; Usuki E; Cheung YL; Hall M; Bridges AS; Loewen G; Parkinson OT; Stephens CE; Allen JL; Zeldin DC; Boykin DW; Tidwell RR; Parkinson A; Paine MF; Hall JE
    Drug Metab Dispos; 2006 Dec; 34(12):1985-94. PubMed ID: 16997912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel metabolites of amodiaquine formed by CYP1A1 and CYP1B1: structure elucidation using electrochemistry, mass spectrometry, and NMR.
    Johansson T; Jurva U; Grönberg G; Weidolf L; Masimirembwa C
    Drug Metab Dispos; 2009 Mar; 37(3):571-9. PubMed ID: 19074972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP1A1 and CYP1B1, two hydrocarbon-inducible cytochromes P450, are constitutively expressed in neonate and adult goat liver, lung and kidney.
    Eltom SE; Schwark WS
    Pharmacol Toxicol; 1999 Aug; 85(2):65-73. PubMed ID: 10488687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential induction of cytochrome P450 1A1 over cytochrome P450 1B1 in human breast epithelial cells following exposure to quercetin.
    Mense SM; Chhabra J; Bhat HK
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):157-62. PubMed ID: 18456490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene.
    Harrigan JA; McGarrigle BP; Sutter TR; Olson JR
    Toxicol In Vitro; 2006 Jun; 20(4):426-38. PubMed ID: 16198082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theoretical investigation of differences in nitroreduction of aristolochic acid I by cytochromes P450 1A1, 1A2 and 1B1.
    Jerabek P; Martinek V; Stiborova M
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():25-32. PubMed ID: 23353840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time polymerase chain reaction analysis of CYP1B1 gene expression in human liver.
    Chang TK; Chen J; Pillay V; Ho JY; Bandiera SM
    Toxicol Sci; 2003 Jan; 71(1):11-9. PubMed ID: 12520071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.
    Androutsopoulos VP; Papakyriakou A; Vourloumis D; Spandidos DA
    Bioorg Med Chem; 2011 May; 19(9):2842-9. PubMed ID: 21482471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1.
    Doostdar H; Burke MD; Mayer RT
    Toxicology; 2000 Apr; 144(1-3):31-8. PubMed ID: 10781868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP1A1-Mediated Intramolecular Rearrangement of Aminoazepane in GDC-0339.
    Takahashi RH; Wang X; Segraves NL; Wang J; Chang JH; Khojasteh SC; Ma S
    Drug Metab Dispos; 2017 Oct; 45(10):1084-1092. PubMed ID: 28790146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status.
    Angus WG; Larsen MC; Jefcoate CR
    Carcinogenesis; 1999 Jun; 20(6):947-55. PubMed ID: 10357772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism.
    Larsen MC; Angus WG; Brake PB; Eltom SE; Sukow KA; Jefcoate CR
    Cancer Res; 1998 Jun; 58(11):2366-74. PubMed ID: 9622076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragmentation study of imatinib and characterization of new imatinib metabolites by liquid chromatography-triple-quadrupole and linear ion trap mass spectrometers.
    Marull M; Rochat B
    J Mass Spectrom; 2006 Mar; 41(3):390-404. PubMed ID: 16470567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP1A1 and CYP1B1 in blood-brain interfaces: CYP1A1-dependent bioactivation of 7,12-dimethylbenz(a)anthracene in endothelial cells.
    Granberg L; Ostergren A; Brandt I; Brittebo EB
    Drug Metab Dispos; 2003 Mar; 31(3):259-65. PubMed ID: 12584151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
    Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.